ResMed, Inc. (RSMDF)
24.52
+2.04
(+9.10%)
USD |
OTCM |
Aug 25, 16:00
ResMed EPS Diluted (Quarterly) : 0.2645 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2645 |
| March 31, 2026 | 0.2736 |
| December 31, 2025 | 0.2682 |
| September 30, 2025 | 0.2373 |
| June 30, 2025 | 0.2582 |
| March 31, 2025 | 0.248 |
| December 31, 2024 | 0.2337 |
| September 30, 2024 | 0.2109 |
| June 30, 2024 | 0.1981 |
| March 31, 2024 | 0.2038 |
| December 31, 2023 | 0.1415 |
| September 30, 2023 | 0.1488 |
| June 30, 2023 | 0.1556 |
| March 31, 2023 | 0.1577 |
| December 31, 2022 | 0.1526 |
| September 30, 2022 | 0.1431 |
| June 30, 2022 | 0.1327 |
| March 31, 2022 | 0.1218 |
| December 31, 2021 | 0.1372 |
| September 30, 2021 | 0.1386 |
| June 30, 2021 | 0.1331 |
| March 31, 2021 | -0.0539 |
| December 31, 2020 | 0.1226 |
| September 30, 2020 | 0.1221 |
| June 30, 2020 | 0.1219 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.112 |
| December 31, 2019 | 0.1103 |
| September 30, 2019 | 0.0828 |
| June 30, 2019 | 0.0475 |
| March 31, 2019 | 0.073 |
| December 31, 2018 | 0.086 |
| September 30, 2018 | 0.073 |
| June 30, 2018 | 0.0763 |
| March 31, 2018 | 0.076 |
| December 31, 2017 | 0.007 |
| September 30, 2017 | 0.06 |
| June 30, 2017 | 0.071 |
| March 31, 2017 | 0.062 |
| December 31, 2016 | 0.054 |
| September 30, 2016 | 0.054 |
| June 30, 2016 | 0.059 |
| March 31, 2016 | 0.064 |
| December 31, 2015 | 0.068 |
| September 30, 2015 | 0.057 |
| June 30, 2015 | 0.061 |
| March 31, 2015 | 0.064 |
| December 31, 2014 | 0.064 |
| September 30, 2014 | 0.058 |
| June 30, 2014 | 0.061 |
| March 31, 2014 | 0.063 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Accuray, Inc. | -0.0154 |
| Orthofix Medical, Inc. | -0.3862 |
| Rockwell Medical, Inc. | -0.3352 |
| Microbot Medical, Inc. | -0.0838 |
| Stereotaxis, Inc. | -0.0478 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 383.43M |
| Revenue (Quarterly) | 1.464B |
| Total Expenses (Quarterly) | 1.080B |
| Enterprise Value | 34.73B |
| Gross Profit Margin (Quarterly) | 58.12% |
| Profit Margin (Quarterly) | 26.20% |
| Earnings Yield | 4.26% |
| Operating Earnings Yield | 5.37% |
| Normalized Earnings Yield | 4.286 |